Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChAdOx1 85A and MVA85A in Ugandan Adults and Adolescents
NCT03681860Phase 2Completed
- Sponsor
- University of Oxford
- Start
- Jul 2019
- Primary completion
- May 2021
- Modality
- Viral Vector Vaccines
- Countries
- 2
01
Overview
Phase 2, randomised, open-label trial of ChAdOx1 85A in Tuberculosis (TB), sponsored by University of Oxford. Started Jul 2019; status: completed.
02
Drugs
ChAdOx1 85A
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT03681860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03681860.